This thesis investigates the potential of open innovation (OI) to support research and development (R&D) activities towards finding novel solutions that help to fight antimicrobial resistances (AMR). The antimicrobial resistance research and development (AMR R&D) industry faces several challenges that delimit novelty creation, including a lack of financial support, complex drug discovery processes and the fast progress of AMR.